fabio canforti

fabio canforti

European Institute of Oncology Milan - Milan / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4686799
person_outline fabio canforti's MOST POPULAR ARTICLES
1-) Cancer immunotherapy efficacy and patients\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\' sex: a systematic review and meta-analysisF Conforti, L Pala, V Bagnardi, T De Pas, M Martinetti, G Viale, RD Gelber, ...The Lancet Oncology 19 (6), 737-746, 20187432018
2-) Talimogene laherparepvec (T-VEC): an intralesional cancer immunotherapy for advanced melanomaPF Ferrucci, L Pala, F Conforti, E CocorocchioCancers 13 (6), 1383, 20211632021
3-) Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysisF Conforti, L Pala, V Bagnardi, G Viale, T De Pas, E Pagan, ...JNCI: Journal of the National Cancer Institute 111 (8), 772-781, 20191632019
4-) Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialF Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ...Journal of translational medicine 18 (1), 405, 20201542020
5-) Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapyPA Zucali, T De Pas, G Palmieri, A Favaretto, A Chella, M Tiseo, M Caruso, ...Journal of Clinical Oncology 36 (4), 342-349, 20181482018